Vera Therapeutics (VERA) Other Non-Current Assets (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Other Non-Current Assets data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 917.54% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 917.54% YoY), and the FY2025 full-year result was $2.5 million, up 1787.79% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.2 million, down from $2.5 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.6 million in Q2 2025 and bottomed at $38000.0 in Q2 2023.
• The 5-year median for Other Non-Current Assets is $293000.0 (2022), against an average of $774941.2.
• The widest annual swing landed in 2023, when Other Non-Current Assets sank 87.03%; it then soared 2043.57% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $162000.0 in 2022, then surged by 197.53% to $482000.0 in 2023, then tumbled by 72.82% to $131000.0 in 2024, then surged by 1787.79% to $2.5 million in 2025, then slumped by 53.09% to $1.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.2 million (Q1 2026), $2.5 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.

Peer Comparison